2012
DOI: 10.1074/jbc.m112.360081
|View full text |Cite
|
Sign up to set email alerts
|

The ABCG5 ABCG8 Sterol Transporter Opposes the Development of Fatty Liver Disease and Loss of Glycemic Control Independently of Phytosterol Accumulation

Abstract: Background: G5G8 promotes elimination of cholesterol. Results: The absence of G5G8 accelerates the loss of glycemic control and exacerbates the development of steatosis. Conclusion: G5G8 mitigates the impact of a high fat diet on hepatic lipid accumulation and glucose intolerance. Significance: Increased G5G8 in insulin resistance may be an adaptive mechanism that opposes steatosis but increases the risk of cholesterol gallstones.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 51 publications
(42 citation statements)
references
References 42 publications
1
38
0
2
Order By: Relevance
“…77,78) 3.2. ABCG5/G8 and Gallstone Although ABCG5/G8 KO mice showed increased liver weight, hepatic lipids accumulation, higher plasma ALT, and increased fasting glucose levels compared with WT mice, 79) there is little information on liver histology and glucose metabolism in patients with sitosterolemia except for one patient with chronic active hepatitis and signs of cirrhosis. 80) Meanwhile, associations of cholesterol gallstone disease with mutations of ABCG5/G8 have been revealed in humans by a number of gene mutation analyses and GWAS.…”
Section: Fig 4 Drug Interaction Between Ezetimibe and Warfarinmentioning
confidence: 99%
“…77,78) 3.2. ABCG5/G8 and Gallstone Although ABCG5/G8 KO mice showed increased liver weight, hepatic lipids accumulation, higher plasma ALT, and increased fasting glucose levels compared with WT mice, 79) there is little information on liver histology and glucose metabolism in patients with sitosterolemia except for one patient with chronic active hepatitis and signs of cirrhosis. 80) Meanwhile, associations of cholesterol gallstone disease with mutations of ABCG5/G8 have been revealed in humans by a number of gene mutation analyses and GWAS.…”
Section: Fig 4 Drug Interaction Between Ezetimibe and Warfarinmentioning
confidence: 99%
“…Urso capsules, USP (NDC 42806-503-01) were purchased from Epic Pharma LLC, and Zetia (EZ) tablets (NDC 66582-414-54) from Merck and Co. Inc. Urethane, bromodeoxyuridine (BrdU), and the silylation reagent N , O -bis (trimethylsilyl) trifl uoroacetamide were purchased from SigmaAldrich. The chicken anti-G5 polyclonal antibody and the monoclonal antibody directed against G8 were previously reported ( 6,14 ). The ␤ -actin antibody was purchased from Sigma.…”
Section: Chemicals Reagents and Antibodiesmentioning
confidence: 99%
“…The ␤ -actin antibody was purchased from Sigma. Anti-ABCA1, [26, 26, 26, 27, 27, 27-2 H 6 ]cholesterol and [5,6,22, H 4 ]sitostanol were generous gifts from Ryan Temel (University of Kentucky) ( 15 ). The anti-CD3 monoclonal antibody (clone 145-2C11) was purifi ed over protein G beads (Amersham Pharmacia Biotech, Piscataway, NJ).…”
Section: Chemicals Reagents and Antibodiesmentioning
confidence: 99%
See 2 more Smart Citations